Stefan Westin

Title: The Innovative Contributions of Stefan Westin

Introduction

Stefan Westin is a notable inventor based in San Diego, California. He has made significant contributions to the field of biomedical research, particularly in the development of assays for detecting important biomarkers in blood samples. With a total of two patents to his name, Westin's work has the potential to impact patient diagnostics and treatment.

Latest Patents

Westin's latest patents include an assay method for the detection of VCAM-1 and alpha-2-macroglobulin in blood. This innovative method utilizes fluorescence resonance energy transfer (FRET) to detect the presence or amounts of these biomarkers in a sample. His second patent focuses on indirect homogeneous mobility shift assays for the detection of biologics in patient samples. This invention provides a sensitive and specific assay using size exclusion chromatography to measure biologics such as vedolizumab and ustekinumab. The assays are particularly advantageous for detecting biologics that target complex or large antigens, including cell surface proteins and heavily glycosylated proteins.

Career Highlights

Throughout his career, Stefan Westin has worked with prominent companies in the biomedical field, including ProciseDx Inc. and Prometheus Laboratories Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical diagnostics.

Collaborations

Westin has collaborated with talented individuals in his field, including Hongyu Chen and Limin Liu. These collaborations have likely enhanced the quality and impact of his inventions.

Conclusion

Stefan Westin's contributions to biomedical research through his innovative patents demonstrate his commitment to improving patient care. His work in developing advanced assay methods is paving the way for more effective diagnostics in the medical field.